Abcam plc (ABC), the online antibody sales company reported that sales increased 49.7% to £36.7m ($65.47m) in the year to June 30, while adjusted pretax profits increased 48.2% to £8.2m. The company boosted its final dividend by 42.9% to 4.56p per share, making a total dividend for the year of 5.6p.
Chairman David Cleevely said in a statement: ‘The growing international demand for research antibodies, combined with the strength of our brand, product range and strategy, means that the board looks forward to the future with confidence’
ABCAM PLC – ABC – Directorate Change
On 16 June 2020, Abcam plc announced that Jonathan Milner, co-founder and Non-Executive Deputy Chairman of Abcam, had informed the Board that he would be standing down from the Board in due course, to allow him to focus on his growing portfolio of early stage company investments.